Congress · 116th Congress
Oversight Democrats investigate whether CDC and HIV prevention drugmaker made a deal
[jwp-video n=”1″] The company estimates it has spent $1.1 billion on research and development related to Truvada. Advocates with PrEP4All found that the CDC holds patents on the drug.